tiprankstipranks
Trending News
More News >
Synopsys (SNPS)
NASDAQ:SNPS

Synopsys (SNPS) AI Stock Analysis

Compare
5,119 Followers

Top Page

SNPS

Synopsys

(NASDAQ:SNPS)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 5.2)
Rating:66Neutral
Price Target:
$447.00
▲(1.06% Upside)
Action:ReiteratedDate:03/03/26
The score is driven primarily by strong cash generation and solid underlying financial performance, reinforced by a constructive earnings update (EPS guidance raised, strong backlog and free cash flow, and Ansys integration momentum). These positives are tempered by weak technical trend signals and a high valuation multiple, which increase downside sensitivity if margins or integration execution weaken.
Positive Factors
Robust free cash flow
Strong and growing free cash flow (TTM FCF up ~69% and FCF near reported earnings) provides durable internal funding for R&D, share repurchases, debt repayment and acquisitions. High cash conversion underpins financial flexibility and supports multi‑year strategic investments and shareholder returns.
High gross margins & product leadership
Very high gross margins and strong design automation operating profitability reflect a defensible software/IP business model with pricing power. Technical wins (100% usage on 2nm+ tape‑outs, marquee AI/HPC client wins) reinforce long‑term competitive advantage in cutting‑edge semiconductor toolsets.
Ansys integration and backlog visibility
Material contribution from Ansys and an $11.3B backlog give multi‑quarter revenue visibility and structural cross‑sell potential. Targeted $400M run‑rate revenue synergies and cost synergies imply durable top‑line and margin lift over several years as integration scales and joint solutions monetize.
Negative Factors
Elevated absolute debt
A $10B debt load is a persistent structural risk that can limit strategic flexibility if margins or cash generation weaken. Mixed leverage signals across periods reduce confidence in capital structure trends and increase sensitivity to interest, refinancing and M&A funding costs over the medium term.
Design IP revenue decline & margin pressure
A transitional year for IP with declining revenue and compressed margins creates a multi‑quarter headwind to consolidated profitability. Continued investment to deliver new IP and timing/delivery risk means sustained margin drag until new titles scale and monetize, pressuring segment ROIC.
China and end‑market softness
Geopolitical restrictions, stronger domestic competitors, and softer design starts in consumer, automotive and industrial markets create structural regional and end‑market risks. Reliance on AI/cloud demand concentrates exposure and may leave revenue cyclicality outside AI end markets.

Synopsys (SNPS) vs. SPDR S&P 500 ETF (SPY)

Synopsys Business Overview & Revenue Model

Company DescriptionSynopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company offers Fusion Design Platform that provides digital design implementation solutions; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. It also provides intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy applications; analog IP, including data converters and audio codecs; and system-on-chip (SoC) infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating-point components, and Arm AMBA interconnect fabric and peripherals. In addition, the company offers logic libraries and embedded memories; configurable processor cores and application-specific instruction-set processor tools for embedded applications; IP subsystems for audio, sensor, and data fusion functionality; and security IP solutions. Further, it provides Platform Architect solutions for SoC architecture analysis and optimization; virtual prototyping solutions; and HAPS FPGA-based prototyping systems, as well as a series of tools used in the design of optical systems and photonic devices. Additionally, the company offers security testing, managed services, programs and professional services, and training that enable its customers to detect and remediate security vulnerabilities, and defects in the software development lifecycle, as well as manufacturing solutions. It serves electronics, financial services, automotive, medicine, energy, and industrial areas. The company was incorporated in 1986 and is headquartered in Mountain View, California.
How the Company Makes MoneySynopsys generates revenue primarily through the sale of software licenses for its EDA tools and related services, which include software support and maintenance, training, and consulting. The company operates on a subscription-based model for many of its products, providing a steady stream of recurring revenue. Additionally, Synopsys earns significant income from its semiconductor IP business, which licenses technology to other companies for use in their chip designs. Strategic partnerships with major technology firms and ongoing investments in research and development further enhance its product offerings, contributing to its financial growth. The company also benefits from the increasing demand for advanced semiconductor solutions driven by trends such as artificial intelligence, automotive automation, and the Internet of Things (IoT).

Synopsys Key Performance Indicators (KPIs)

Any
Any
Revenue by Type
Revenue by Type
Breaks down revenue streams, highlighting which product or service types contribute most to the company’s top line and potential areas for growth.
Chart InsightsSynopsys's Products revenue shows a consistent upward trend, reflecting strong demand and strategic growth initiatives. The Maintenance and Services segment, however, experienced a significant spike in 2025, likely driven by the successful integration of ANSYS and increased demand for AI-driven solutions. The earnings call highlights a strategic partnership with NVIDIA and a positive outlook for FY 2026, despite challenges in China and a decline in the Design IP segment. These developments suggest Synopsys is well-positioned for continued growth, leveraging AI and strategic partnerships to enhance its market position.
Data provided by:The Fly

Synopsys Earnings Call Summary

Earnings Call Date:Feb 25, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:May 20, 2026
Earnings Call Sentiment Positive
The call emphasized a strong start to FY'26 with revenue at the high end of guidance, a material non-GAAP EPS beat, high non-GAAP margins, robust free cash flow and sizeable backlog. Integration of Ansys is already contributing meaningful revenue and is expected to drive cross-sell and joint-solution monetization over time, while the company is pursuing $400M run-rate revenue synergies and accelerating cost synergies. On the downside, Design IP is in a transitional phase with a ~6% YoY revenue decline, depressed IP margins and some timing/delivery risk for new IP titles. China headwinds and softer consumer/auto/industrial design starts add regional and end-market pressure. Overall, the positive operational execution, strong cash generation, and Acceleration from Ansys integration outweigh the near-term IP and China-related challenges.
Q1-2026 Updates
Positive Updates
Top-Line Beat and Strong Quarter Start
Q1 total revenue of $2.41 billion came in at the high end of guidance, driven in part by approximately $886 million of Ansys revenue; company reiterated full-year revenue guidance of $9.56B–$9.66B.
Earnings and Margins Outperformance
Non-GAAP EPS of $3.77 exceeded guidance; non-GAAP operating margin was 42.1% (Design Automation adjusted operating margin: 47.3%), and full-year non-GAAP EPS guidance was raised to $14.38–$14.46 (up $0.06).
Strong Cash Generation and Capital Actions
Q1 free cash flow of approximately $822 million; cash and short-term investments of $2.2 billion; operating cash flow guidance ~ $2.2 billion and free cash flow guidance ~ $1.9 billion for the year; Board authorized up to $2 billion for share repurchases and the $4.3 billion term loan was fully repaid.
Healthy Backlog and Visibility
Backlog (RPO) ended at $11.3 billion, providing strong revenue visibility despite near-term volatility in some end markets.
Ansys Integration and Revenue Contribution
Ansys contributed about $886M in Q1; management expects ~ $2.9B Ansys revenue at the FY midpoint and double-digit growth from Ansys, with cross-selling underway and committed revenue synergies target of $400M run-rate by year 4.
Product & Technology Momentum — AI and Hardware Wins
Synopsys reported major wins (including a marquee emulation win vs. an incumbent at a leading AI/HPC customer), Fusion Compiler and PrimeTime achieved 100% usage on critical 2nm+ tape-outs, and hardware-assisted verification (ZeBu/HAPS/EP) remains in strong demand.
AI Productivity Gains Demonstrated
Synopsys.ai customer results cited: up to 50% faster knowledge assistance, up to 70% faster workflow assistance and up to 5x faster formal test bench generation, positioning Synopsys for AI-driven engineering efficiency gains.
IP Market Leadership in Key Interfaces
Design IP saw >40 PCIe design wins in the quarter, an industry-first PCIe 8.0 demo, and first-to-market 224G SerDes with 10 lifetime wins — supporting longer-term conviction in interface IP demand.
Negative Updates
Design IP Revenue Decline and Transitional Year
Design IP revenue was $407 million, down approximately 6% year-over-year and flat sequentially; management reiterated FY'26 will be a transitional year for IP with muted growth expected.
Compressed IP Operating Margin
Design IP adjusted operating margin was 16.2%, materially below corporate margins; management attributed the compression to muted revenue while investments to deliver new IP titles continue.
Delivery Timing and Scheduling Risk in IP
Management acknowledged scheduling and delivery timing issues for several IP titles (some monetization expected later in the year and Q4-weighted availability), creating execution risk for IP revenue recognition this fiscal year.
China Headwinds and Market Variability
China revenue grew ~21% YoY in Q1 due to the inclusion of Ansys; excluding Ansys, China revenue declined slightly YoY. Management cited ongoing geopolitical and technology restrictions and increased domestic competitor activity as headwinds.
End-Market Softness Outside AI
While AI infrastructure design starts remain robust, management noted subdued design starts in consumer, automotive and industrial markets, which limits broader near-term demand recovery.
GAAP vs Non-GAAP Differential and Debt Level
GAAP EPS was $0.34 versus non-GAAP $3.77; management highlighted amortization and other GAAP items driving the delta. Total debt remains elevated at $10 billion despite repayment of the $4.3B term loan.
Company Guidance
Synopsys reiterated full‑year targets while raising non‑GAAP EPS and provided detailed Q1/Q2 metrics: Q1 revenue was $2.41B (Ansys ~$886M), backlog $11.3B, total cash & short‑term investments $2.2B, total debt $10B (term loans of $4.3B repaid), GAAP EPS $0.34 and non‑GAAP EPS $3.77, non‑GAAP operating margin 42.1% (Q1 non‑GAAP costs $1.4B), free cash flow ~$822M; by segment Design Automation revenue was ~$2.0B with a 47.3% adjusted operating margin and Design IP was $407M (‑6% y/y) with a 16.2% margin. Full‑year guidance: revenue $9.56B–$9.66B (Ansys ~$2.9B at midpoint, growing double digits), GAAP costs $8.46B–$8.60B, non‑GAAP costs $5.69B–$5.75B (non‑GAAP operating margin ~40.5% at midpoint), GAAP EPS $2.21–$2.62, non‑GAAP EPS $14.38–$14.46 (up $0.06), operating cash flow ~$2.2B, CapEx ~$300M, and free cash flow ~$1.9B; Q2 targets: revenue $2.225B–$2.275B, GAAP costs $2.02B–$2.085B, non‑GAAP costs $1.38B–$1.41B, GAAP EPS $0.23–$0.43 and non‑GAAP EPS $3.11–$3.17, and the Board authorized up to $2B in share repurchases.

Synopsys Financial Statement Overview

Summary
Strong overall fundamentals led by high gross margins (~75%) and robust, accelerating free cash flow (TTM FCF up sharply and close to net income). Offsetting this, TTM profitability has softened (net margin down vs. prior annual period) and balance-sheet trend signals are mixed, reducing confidence in leverage/return trajectory.
Income Statement
78
Positive
Revenue has grown steadily over the past several years (roughly 10–15% annually), and profitability remains strong with TTM (Trailing-Twelve-Months) gross margin around 75%. However, margins and earnings quality have softened in TTM versus the last annual period: net margin fell to ~14% from ~19% annually, and operating profitability is also lower than the prior year, suggesting either higher costs, investment ramp, or less favorable mix. Overall: solid growth and high gross profitability, but with a noticeable recent step-down in bottom-line margin.
Balance Sheet
62
Positive
The balance sheet shows very large equity and assets in the latest period, but leverage and capital structure look inconsistent across periods. Annual data shows moderate leverage in 2025 (debt-to-equity ~0.50) versus low leverage in 2022–2024, while TTM (Trailing-Twelve-Months) reports extremely low debt-to-equity (~0.02) despite a high absolute debt balance—this limits confidence in trend interpretation. Returns on equity are positive but modest in the latest period (~4–5%) and well below the unusually high 2023–2024 levels, pointing to reduced profitability on a larger equity base. Overall: appears adequately capitalized, but with mixed leverage signals and weaker recent returns.
Cash Flow
84
Very Positive
Cash generation is a key strength. TTM (Trailing-Twelve-Months) operating cash flow and free cash flow are both strong, with free cash flow up sharply (about +69% TTM) and free cash flow close to reported earnings (FCF running at ~93% of net income), supporting earnings quality. A watch item is that operating cash flow relative to earnings is not consistently high (coverage ratios in the ~0.4–0.6 range historically and ~0.62 TTM), but the overall level and growth in free cash flow remain very constructive.
BreakdownTTMOct 2025Oct 2024Oct 2023Oct 2022Oct 2021
Income Statement
Total Revenue8.01B7.05B6.13B5.32B4.62B4.20B
Gross Profit6.02B5.43B4.88B4.29B3.72B3.34B
EBITDA2.64B2.50B1.85B1.56B1.33B1.01B
Net Income1.10B1.33B2.26B1.23B984.59M757.52M
Balance Sheet
Total Assets47.24B48.22B13.07B10.33B9.42B8.75B
Cash, Cash Equivalents and Short-Term Investments2.20B2.96B4.05B1.59B1.57B1.58B
Total Debt10.04B14.29B684.46M677.60M656.37M666.77M
Total Liabilities16.69B19.90B4.05B4.15B3.86B3.45B
Stockholders Equity30.55B28.33B8.99B6.15B5.52B5.30B
Cash Flow
Free Cash Flow2.28B1.35B1.28B1.51B1.60B1.40B
Operating Cash Flow2.44B1.52B1.41B1.70B1.74B1.49B
Investing Cash Flow-15.90B-15.91B1.22B-482.10M-572.62M-549.03M
Financing Cash Flow11.80B13.39B-181.30M-1.20B-1.12B-748.75M

Synopsys Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price442.30
Price Trends
50DMA
467.69
Negative
100DMA
451.23
Negative
200DMA
493.93
Negative
Market Momentum
MACD
-9.20
Negative
RSI
49.81
Neutral
STOCH
56.42
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SNPS, the sentiment is Neutral. The current price of 442.3 is above the 20-day moving average (MA) of 431.60, below the 50-day MA of 467.69, and below the 200-day MA of 493.93, indicating a neutral trend. The MACD of -9.20 indicates Negative momentum. The RSI at 49.81 is Neutral, neither overbought nor oversold. The STOCH value of 56.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SNPS.

Synopsys Risk Analysis

Synopsys disclosed 29 risk factors in its most recent earnings report. Synopsys reported the most risks in the "Tech & Innovation" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Synopsys Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$115.65B19.1355.43%10.53%34.24%
72
Outperform
$62.46B31.84135.72%14.78%22.52%
72
Outperform
$133.14B71.1816.26%15.30%-60.71%
66
Neutral
$26.04B-232.70-3.56%23.24%-8.83%
66
Neutral
$84.73B287.805.55%12.62%-45.12%
65
Neutral
$444.88B23.4570.60%1.00%11.08%29.56%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SNPS
Synopsys
442.30
-8.58
-1.90%
ADBE
Adobe
281.74
-167.66
-37.31%
FTNT
Fortinet
84.42
-16.86
-16.65%
ORCL
Oracle
154.79
1.19
0.77%
PANW
Palo Alto Networks
163.16
-17.77
-9.82%
ZS
Zscaler
161.96
-46.80
-22.42%

Synopsys Corporate Events

Business Operations and StrategyStock Buyback
Synopsys Launches $250 Million Accelerated Share Repurchase
Positive
Mar 2, 2026

On March 2, 2026, Synopsys announced it had entered into a $250 million accelerated share repurchase agreement with The Bank of Nova Scotia to buy back its common stock. The move underlines the company’s capital return strategy and could signal confidence in its valuation, with implications for earnings per share and shareholder returns.

Under the agreement, Synopsys is set to receive an initial delivery of about 513,000 shares, with the final number of shares to be determined based on the volume-weighted average price of its stock during the repurchase period, less a discount. Settlement of any remaining shares is expected on or before June 1, 2026, tying the ultimate size of the buyback to market conditions over the coming months.

The most recent analyst rating on (SNPS) stock is a Hold with a $480.00 price target. To see the full list of analyst forecasts on Synopsys stock, see the SNPS Stock Forecast page.

Business Operations and StrategyStock BuybackFinancial Disclosures
Synopsys Posts Strong Q1 Results, Expands Buyback Program
Positive
Feb 25, 2026

On Feb. 25, 2026, Synopsys reported first-quarter fiscal 2026 revenue of $2.409 billion, up from $1.455 billion a year earlier, with GAAP EPS of $0.34 and non-GAAP EPS of $3.77, both at or above guidance. Management highlighted strong execution, an AI-driven uplift in system-level and semiconductor R&D demand, and reiterated full-year revenue expectations around $9.61 billion, including a sizable Ansys contribution.

The board also replenished Synopsys’ stock repurchase program, authorizing buybacks of up to $2 billion of common stock, a move that underscores confidence in the company’s growth trajectory and capital-return strategy. Synopsys issued financial targets for the second quarter and full fiscal 2026, signaling continued investment discipline as it seeks to capitalize on an expanded market opportunity and reinforce its competitive position in chip design and systems engineering tools.

The most recent analyst rating on (SNPS) stock is a Hold with a $455.00 price target. To see the full list of analyst forecasts on Synopsys stock, see the SNPS Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Synopsys Updates Board as Part of Governance Refresh
Positive
Feb 19, 2026

On February 14, 2026, Synopsys’ board expanded from eleven to twelve members and appointed former Deloitte executive Peter A. Shimer as an independent director and audit committee member, effective immediately. Shimer, an audit committee financial expert with four decades at Deloitte and current roles at Alaska Air Group and cancer-focused AI initiatives, will receive standard non-employee director compensation, reinforcing Synopsys’ financial oversight as it scales its AI-driven silicon-to-systems platform.

In a related February 19, 2026 announcement, Synopsys said it would not renominate directors Luis Borgen and Dr. Ajei Gopal for re-election, though both will serve until the 2026 annual meeting. The board framed these moves, which come as the Ansys integration progresses, as part of a broader commitment to director refreshment and governance evolution to support the company’s leadership in the growing silicon-to-systems engineering market.

The most recent analyst rating on (SNPS) stock is a Buy with a $560.00 price target. To see the full list of analyst forecasts on Synopsys stock, see the SNPS Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 03, 2026